benzyl isothiocyanate has been researched along with sulforaphane in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 11 (68.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, S; Desai, D; Emmert, SW; Richie, JP | 1 |
| Chung, FL; Di Pasqua, AJ; Fine, RL; Govind, S; Hong, C; Mao, Y; McCracken, E; Mi, L; Tomita, Y; Wang, X; Woodrick, JC; Wu, JY | 1 |
| Dale, EJ; Gamble, AB; Gommans, AL; Hampton, MB; Nakatani, Y; Rutledge, MT; Smith, RA; Spencer, ES; Tyndall, JD; Vo, CT; Wilbanks, SM | 1 |
| Catalano, MJ; Gates, KS; Laciak, AR; Lewis, SM; Li, Y; Reilly, TJ; Seiner, DR; Singh, H; Tanner, JJ | 1 |
| Gajda, A; Gajda, T; Goszczyński, TM; Janczewski, Ł; Oleksyszyn, J; Psurski, M; Świtalska, M; Wietrzyk, J | 1 |
| Ciekot, J; Gajda, A; Gajda, T; Goszczyński, TM; Janczewski, Ł; Oleksyszyn, J; Psurski, M; Świtalska, M; Wietrzyk, J; Winiarski, Ł | 1 |
| Hecht, SS; Kenney, PM; Upadhyaya, P; Wang, M | 1 |
| Hirose, M; Ishii, Y; Kanki, K; Kitamura, Y; Kuroiwa, Y; Nishikawa, A; Umemura, T | 1 |
| Li, G; Song, L; Tang, L; Zhang, Y | 1 |
| Chung, FL; Mi, L | 1 |
| Chung, FL; Gan, N; Mi, L | 1 |
| Kumar, A; Sabbioni, G | 1 |
| Han, W; Shi, M; Spivack, SD; Tan, XL; Tang, H | 1 |
| Chang, IS; Chen, HW; Huang, CS; Lii, CK; Lin, AH; Liu, CT; Tsai, CW | 1 |
| Amjad, AI; Chinni, SR; Parikh, R; Sakao, K; Singh, SV; Vyas, AR | 1 |
| Bae, YS; Chang, HW; Chang, YC; Cho, HJ; Chung, IK; Jeong, YJ; Jin, F; Kim, CH; Kim, M; Lee, CS; Park, KK; Park, YY; Shin, JM | 1 |
16 other study(ies) available for benzyl isothiocyanate and sulforaphane
| Article | Year |
|---|---|
Enhanced Nrf2-dependent induction of glutathione in mouse embryonic fibroblasts by isoselenocyanate analog of sulforaphane.
Topics: Animals; Cell Line, Tumor; Cyanates; Embryo, Mammalian; Fibroblasts; Glutathione; Humans; Isothiocyanates; Mice; NF-E2-Related Factor 2; Sulfoxides; Thiocyanates | 2010 |
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
Topics: Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Cysteine; Drug Screening Assays, Antitumor; Humans; Isothiocyanates; Mutation; Protein Conformation; Structure-Activity Relationship; Tumor Suppressor Protein p53 | 2011 |
Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
Topics: Drug Design; Enzyme Inhibitors; Humans; Intramolecular Oxidoreductases; Isothiocyanates; Jurkat Cells; Macrophage Migration-Inhibitory Factors; Molecular Docking Simulation; Protein Binding; Protein Conformation | 2015 |
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
Topics: Diet; Dose-Response Relationship, Drug; Eating; Enzyme Inhibitors; Humans; Isothiocyanates; Molecular Structure; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Structure-Activity Relationship | 2015 |
Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Humans; Isothiocyanates; Mice; Organophosphonates; Sulfoxides | 2017 |
Phosphorus-containing isothiocyanate-derived mercapturic acids as a useful alternative for parental isothiocyanates in experimental oncology.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Humans; Isothiocyanates; Magnetic Resonance Spectroscopy; Mass Spectrometry; Neoplasms, Experimental; Phosphorus; Spectrophotometry, Infrared | 2018 |
Benzyl isothiocyanate: an effective inhibitor of polycyclic aromatic hydrocarbon tumorigenesis in A/J mouse lung.
Topics: Animals; Anticarcinogenic Agents; Benzo(a)pyrene; Butylated Hydroxyanisole; Carcinogens; Chrysenes; Diet; Dose-Response Relationship, Drug; Female; Incidence; Isothiocyanates; Lung Neoplasms; Mice; Mice, Inbred A; Sulfoxides; Thiocyanates | 2002 |
Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Carcinogenicity Tests; Carcinogens; Cell Transformation, Neoplastic; Cricetinae; Cyclooxygenase 2; Diet; Injections, Subcutaneous; Isothiocyanates; Male; Membrane Proteins; Mesocricetus; Neoplasms, Experimental; Nitrosamines; Pancreatic Neoplasms; Resveratrol; Stilbenes; Sulfoxides; Thiocyanates | 2006 |
The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells.
Topics: Acetylcysteine; Apoptosis; Cell Cycle; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Isothiocyanates; Sulfoxides; Thiocyanates; Urinary Bladder Neoplasms | 2006 |
Binding to protein by isothiocyanates: a potential mechanism for apoptosis induction in human non small lung cancer cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cysteine; DNA Damage; Humans; Isothiocyanates; Lung Neoplasms; Oxidative Stress; Protein Binding; Protein Carbonylation; Sulfoxides; Thiocyanates; Tubulin | 2008 |
Aggresome-like structure induced by isothiocyanates is novel proteasome-dependent degradation machinery.
Topics: Anticarcinogenic Agents; Biomarkers; Cytoplasm; HeLa Cells; Humans; Isothiocyanates; Proteasome Endopeptidase Complex; Protein Folding; Sulfoxides; Thiocyanates; Tubulin | 2009 |
New biomarkers for monitoring the levels of isothiocyanates in humans.
Topics: Animals; Biomarkers; Chromatography, High Pressure Liquid; Hemoglobins; Humans; Isothiocyanates; Kinetics; Lysine; Mice; Rats; Serum Albumin; Spectrometry, Mass, Electrospray Ionization; Sulfoxides; Thiocyanates | 2010 |
Candidate dietary phytochemicals modulate expression of phase II enzymes GSTP1 and NQO1 in human lung cells.
Topics: Anticarcinogenic Agents; Brassica; Bronchi; Camellia sinensis; Catechin; Cell Division; Cell Line; Cell Line, Tumor; Epithelial Cells; Gene Expression; Glutathione S-Transferase pi; Humans; Isothiocyanates; Lung; Lung Neoplasms; NAD(P)H Dehydrogenase (Quinone); Plant Extracts; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfoxides; Thiocyanates | 2010 |
Isothiocyanates protect against oxidized LDL-induced endothelial dysfunction by upregulating Nrf2-dependent antioxidation and suppressing NFκB activation.
Topics: Antioxidant Response Elements; Antioxidants; Cell Adhesion; Dose-Response Relationship, Drug; E-Selectin; Glutamate-Cysteine Ligase; Heme Oxygenase-1; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Adhesion Molecule-1; Isothiocyanates; Leukocytes; Lipoproteins, LDL; NF-E2-Related Factor 2; NF-kappa B; Reactive Oxygen Species; Sulfoxides; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2013 |
CXCR4 is a novel target of cancer chemopreventative isothiocyanates in prostate cancer cells.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Cell Line, Tumor; Chemoprevention; Humans; Isothiocyanates; Male; Mice; Mice, Transgenic; Molecular Targeted Therapy; Prostatic Neoplasms; Receptors, CXCR4; RNA, Small Interfering; Sulfoxides; Xenograft Model Antitumor Assays | 2015 |
Isothiocyanates inhibit the invasion and migration of C6 glioma cells by blocking FAK/JNK-mediated MMP-9 expression.
Topics: Cell Line, Tumor; Cell Movement; Extracellular Matrix; Focal Adhesion Kinase 1; Gene Expression Regulation, Neoplastic; Glioma; Humans; Isothiocyanates; MAP Kinase Kinase 4; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Sulfoxides; Transcription Factor AP-1 | 2015 |